Skip to content

Clinical trials

Phase 1/2 Vision Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vision Disorders Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20172
20194
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ProQR Therapeutics2
Asalus Medical Instruments Limited1
Beacon Therapeutics1
Boston Children's Hospital1
Editas Medicine, Inc.1
Eyestem Research Pvt. Ltd.1
George Washington University1
Laboratoires Thea1
National Eye Institute (NEI)1
eyeDNA Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vision Disorders11
Eye Diseases6
Retinal Diseases6
Eye Diseases, Hereditary5
Eye Abnormalities3
Retinitis Pigmentosa3
Leber Congenital Amaurosis2
Neurologic Manifestations2
Retinal Degeneration2
Retinal Dystrophies2

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.